B. Riley analyst Mayank Mamtani reiterates a Buy rating on Viking Therapeutics (VKTX) with a $96 price target after the ...

Operator: Good morning and welcome to Agenus Inc.’s Fourth Quarter and Year-End 2024 Earnings Conference Call. Currently all ...

Good morning, and welcome to Agenus Inc.'s fourth-quarter and year-end 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. I will now turn the call ...

Good morning, and welcome to Agenus Inc.'s fourth-quarter and year-end 2024 earnings conference call. Currently, all ...

In a report released today, Mayank Mamtani from B.Riley Financial reiterated a Buy rating on Cytokinetics (CYTK – Research Report), with a ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on TG Therapeutics (TGTX – Research Report), ...

Management provided guidance of $115 million in U.S. BRIUMVI net revenue for Q1 2025 and reiterated the full-year 2025 target of $525 million. January and February 2025 were noted as the highest ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Lemaitre Vascular (LMAT – Research Report), ...

In a report released today, Mayank Mamtani from B.Riley Financial reiterated a Buy rating on Trevi Therapeutics (TRVI – Research Report), with ...

Harrigan, Roger B. Cohen, Danielle Zubka, Roy Rosin, Mohan Balachandran, Qi Long, Andrea Bilger, Lynn M. Schuchter, Mira Mamtani, Lawrence N. Shulman, and Carmen E. Guerra have nothing to disclose.

Livspace's Anuj Srivastava and Al Jazira Capital's Ajit Reddy, alongside Goldman Sachs veterans Deb Dutt and Tushar Patel and head of Citi Ventures Jatin Mamtani also participated in the round. The ...